ArticleJournal of racial and ethnic health disparities2026
U.S. Cannabis Use Trends at the Intersection of Serious Psychological Distress and Race/Ethnicity, 2008-2019.
Article in Journal of racial and ethnic health disparities, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
objectiveMental health conditions and race/ethnicity are independently associated with cannabis use. However, the current prevalence of and trends in cannabis use at the intersection of serious psychological distress (SPD) and race/ethnicity are unknown.
methodsThis study assessed past 30-day cannabis use using data from the 2008-2019 National Survey on Drug Use and Health (n = 484,732). Joinpoint regression examined trends over time, stratified by SPD and race/ethnicity.
resultsThe prevalence of past 30-day cannabis use in the US increased significantly between 2008 and 2019 regardless of racial/ethnic group identification and past-month SPD status. The prevalence of cannabis use in 2019 was significantly greater for individuals with (27.9%) versus without SPD (10.7%) overall (p < 0.001) and within each race/ethnicity.
conclusionsBecause cannabis use prolongs and exacerbates psychiatric symptoms, the disproportionately high and increasing prevalence of cannabis use among people with SPD emphasizes the importance of continued surveillance of cannabis use in this group. This is especially true among intersectional priority populations where particularly large disparities in the prevalence of cannabis use are observed (e.g., Hispanic with SPD versus Hispanic without SPD). Additionally, trends highlight the need to screen all patients for cannabis use, especially patients with SPD and related conditions.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.